Ther Adv Hematol
Ther Adv Hematol
Country: Unknown
Publisher: Unknown
Publication Period: Unknown
127
Papers in Database
Journal Information
Publication Details
Additional Information
Subject Term Count: 1
Last Updated: Aug 05, 2025
Recent Papers
View All 127 PapersInterferons in the treatment of myeloproliferative neoplasms.
Vachhani P, Mascarenhas J, Bose P, Hobbs G, Yacoub A, Palmer JM, Gerds AT, Masarova L, Kuykendall A…
Treatment of multiple myeloma with selinexor: a review.
Huang Q, Zhao R, Xu L, Hao X, Tao S.
When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China.
Liu Y, Yin X, Xu D, Lv Y, Zhu L, Yang M, Yao Q, Jin J, Huang L, Meng H, You L.
Assessment of risk factors for acute graft-<i>versus</i>-host disease post-hematopoietic stem cell transplantation: a r…
Xue L, Song L, Yu X, Yang X, Xia F, Ding X, Huang C, Wu D, Miao L.
Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study.
Oladapo A, Kolodny S, Vredenburg M, Swallow E, Goldschmidt D, Sarathy K, Lopez P, Maitland H, Yee J.
Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center ret…
Zhang Z, Hu Q, Yang C, Chen M, Han B.
Considerations for shared decision management in previously untreated patients with hemophilia A or B.
Astermark J, Blatný J, Königs C, Hermans C, Jiménez-Yuste V, Hart DP.
Cost-effectiveness analysis of axicabtagene ciloleucel as a second-line treatment for diffuse large B-cell lymphoma in …
Li N, Lei J, Zhang J, Cai H, Zheng B, Yang T, Liu M, Hu J.
Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic …
Xu L, Lin S, Xing X, Su Y.
Efficacy of complement inhibitors for patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-a…
Lee J, Lee H, Kim S, Suh HS.